Enovis Announces First Quarter 2023 Results

Strong start to the year with sales growth of 8%, organic growth of 9% and strong EBITDA margin expansionOrganic growth of 9% reflects 19% organic growth in Recon and 4% organic growth in... | May 4, 2023

Related Keywords

Ukraine ,United States ,Russia ,America ,Matt Trerotola ,Derek Leckow ,Enovis Corporation ,European Union Medical Device Regulation ,New York Stock Exchange ,Exchange Commission ,European Union ,York Stock Exchange ,Chief Executive Officer ,Greatest Workplaces ,Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,Consolidated Statements ,Net Income ,Adjusted Net Income Per ,Condensed Consolidated Statements ,Enovis Corporation Stock Exchange ,News ,Information ,Press Release ,Strong ,Start ,O ,The ,Ear ,Ith ,Sales ,Growth ,F ,Rganic ,End ,Bitda ,Margin ,Xpansionorganic ,Eflects ,N ,Econ ,Rowth Enov Us1940145022 ,